The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[(4-tert-butylphenyl)methyl]-2-[(4-fluorophenyl)sulfonylamino]-N-[4-(hydroxycarbamoyl)phenyl]acetamide ID: ALA4560533
PubChem CID: 155558467
Max Phase: Preclinical
Molecular Formula: C26H28FN3O5S
Molecular Weight: 513.59
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)c1ccc(CN(C(=O)CNS(=O)(=O)c2ccc(F)cc2)c2ccc(C(=O)NO)cc2)cc1
Standard InChI: InChI=1S/C26H28FN3O5S/c1-26(2,3)20-8-4-18(5-9-20)17-30(22-12-6-19(7-13-22)25(32)29-33)24(31)16-28-36(34,35)23-14-10-21(27)11-15-23/h4-15,28,33H,16-17H2,1-3H3,(H,29,32)
Standard InChI Key: JXKKJJUGFLVTAG-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 38 0 0 0 0 0 0 0 0999 V2000
34.9824 -15.5844 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.5738 -16.2943 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
35.3949 -16.2896 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.0271 -17.5407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0259 -18.3643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7381 -18.7733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4519 -18.3639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4491 -17.5371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7363 -17.1277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7339 -16.3064 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.4445 -15.8957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0208 -15.8999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1576 -16.3022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8682 -15.8914 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.7379 -19.5946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4496 -20.0075 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.4495 -20.8288 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.0260 -20.0072 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.4421 -15.0744 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.5778 -17.1156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8698 -17.5301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8734 -18.3506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5836 -18.7566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2958 -18.3402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2887 -17.5210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5887 -19.5779 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
31.0164 -15.0827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7227 -14.6732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7185 -13.8568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0080 -13.4513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3003 -13.8681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3079 -14.6832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0025 -12.6341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7074 -12.2207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2920 -12.2303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9955 -11.8163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
9 10 1 0
10 11 1 0
10 12 1 0
11 13 1 0
13 14 1 0
14 2 1 0
6 15 1 0
15 16 1 0
16 17 1 0
15 18 2 0
11 19 2 0
2 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
23 26 1 0
12 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 27 1 0
30 33 1 0
33 34 1 0
33 35 1 0
33 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 513.59Molecular Weight (Monoisotopic): 513.1734AlogP: 3.75#Rotatable Bonds: 8Polar Surface Area: 115.81Molecular Species: NEUTRALHBA: 5HBD: 3#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.09CX Basic pKa: ┄CX LogP: 3.84CX LogD: 3.83Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.31Np Likeness Score: -1.72
References 1. Shouksmith AE, Gawel JM, Nawar N, Sina D, Raouf YS, Bukhari S, He L, Johns AE, Manaswiyoungkul P, Olaoye OO, Cabral AD, Sedighi A, de Araujo ED, Gunning PT.. (2020) Class I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia., 11 (1): [PMID:31938464 ] [10.1021/acsmedchemlett.9b00471 ]